AI Summary & Key Takeaways
AI InsightIn this study, we present LDL apheresis theraphy after the coronary bypass in an adolescent patient having chilhood coronary artery disease because of familial hypercholesterolemia.
📌 3 Key Takeaways
Abstract
Familial hypercholesterolemia is a an autosomal dominant disease characterized by increased plasma levels of cholesterol, skin xanthomas, coronary artery disease and early death occur during childhood. Patients with familial hypercholesterolemia patients, unlike the patients with heterozygous hypercholesterolemia, often resistant to diet and drug therapy and therefore also need additional treatment methods. In this study, we present LDL apheresis theraphy after the coronary bypass in an adolescent patient having chilhood coronary artery disease because of familial hypercholesterolemia.
Özet
Ailesel hiperkolesterolemi çocukluk çağında ortaya çıkan hiperkolesterolemi, deride ksantomlar, koroner arter hastalığı ve ölümle karakterize otozomal dominant geçişli bir hastalıktır. Ailesel hiperkolesterolemi hastaları heterozigot hiperkolesterolemili hastalardan farklı olarak diyet ve ilaç tedavilerine çoğunlukla dirençlidir ve bu sebeple ek tedavi metodlarına da ihtiyaç duyarlar. Bu çalışmada ailesel hiperkolesterolemi tanılı, erken yaşta koroner arter hastalığı sebebiyle koroner bypass ve LDL aferez tedavisi yapılan bir adölesan olguyu sunuyoruz.